Tabrecta (capmatinib) - Novartis
Pharmacological inhibition of MET impairs hepatic regeneration and recovery in a murine model of acetaminophen-induced liver injury. (PubMed, Toxicol Appl Pharmacol) - Oct 10, 2026 - "Overall, MET inhibition using capmatinib notably impaired regeneration and resolution of AILI, without altering peak injury, emphasizing MET's direct role in reparative response." 
Journal • Preclinical • Hepatology • Liver Failure • CCND1
http://www.ncbi.nlm.nih.gov/pubmed/42854925
 
Anne Orr; Bharat Bhushan; George K Michalopoulos; Gillian Williams; Ranjan Mukherjee; Saidikrom Mardiev; Siddhi Jain
 
Oct 10, 2026
 
Prev Next